Government Leaders Call for Expanded Biotech Workforce Development, Private-Public Partnerships to Unleash Biotechnology Innovation

Today, Commissioners from the National Security Commission on Emerging Biotechnology (NSCEB), along with Senator Chris Coons (D-DE) and Representative Sarah McBride (D-DE), visited the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to see firsthand how government and industry partnerships drive excellence in innovation and workforce development.

Following the recent release of the Biotech Commission’s report on strengthening the biotechnology industry, Commissioners toured NIIMBL’s state-of-the-art facility and participated in a roundtable discussion on the value of a public-private partnership model to accelerate workforce development for a future growth industry like biotechnology.

NIIMBL is a public-private partnership established in 2017 with a focus on accelerating biopharmaceutical innovation, developing and scaling advanced manufacturing technologies, and supporting workforce development through training programs and curriculum development.

The NSCEB’s recent action plan for American biotechnology highlights the need for more private-led, public-supported innovation in biotechnology and emphasizes the need for dedicated workforce development programs to strengthen the domestic biomanufacturing industry.

Delaware is a hub of biotechnology investment and innovation, showing the potential of biotechnology to bring industry, academia, and government together for regional economic development opportunities that can benefit the nation.